Latest Carbonic anhydrase Stories
TSXV: CST Outstanding shares: 60,261,136 Canadian and Australian patents further broaden CO(2) Solution's intellectual property coverage in the growing global market for carbon capture QUEBEC CITY, May 26, 2011 /PRNewswire/ - CO(2) Solution Inc.
TSX-V: CST Outstanding shares: 60,261,136 QUEBEC CITY and DELFT, Netherlands, Dec. 15 /PRNewswire/ - CO(2) Solution Inc. is pleased to congratulate Dr. Roger Sheldon on his recent receipt of two prestigious awards in the fields of Green Chemistry and Biocatalysis.Â Dr.
Cost Effective Technology Targets Major Source of Greenhouse Gases, Air Pollution from Coal-Fired Power Plants TSX-V: CSTÂ Outstanding shares: 60,261,136Â QUEBEC CITY, Dec. 3 /PRNewswire/ - CO(2) Solution Inc.
TSX-V: CSTÂ Outstanding shares: 60,261,136 QUEBEC CITY, Nov. 17 /PRNewswire-FirstCall/ - CO(2) Solution Inc.
New patent covers use of carbonic anhydrase enzyme for carbon capture with amine solvents; supports commercialization of low-cost carbon capture systems TSX-V: CST Outstanding shares: 60,261,136 QUEBEC CITY, June 29 /PRNewswire-FirstCall/ - CO2 Solution Inc.
TSX-V: CST Outstanding shares: 60,261,136 Agreement with CLEA Technologies B.V. provides CO2 Solution with advanced technology for industrial application of enzyme for carbon capture QUEBEC CITY, June 1 /PRNewswire-FirstCall/ - CO2 Solution Inc.
Biologists have identified plant enzymes that may help to engineer plants that take advantage of elevated carbon dioxide to use water more efficiently.
New results achieved with proprietary, patented enzyme show potential to dramatically lower the cost of large-scale CO2 capture Trading symbol: CST Outstanding shares: 50,261,136 QUEBEC, Nov. 25 /PRNewswire-FirstCall/ - CO2 Solution Inc.
- The horn of a unicorn considered as a medical or pharmacological ingredient.
- A winged horse with a single horn on its head; a winged unicorn.